Do you have the same question? Follow this Question
Oct 24, 2024 - 01:53 PM
We’ve provided several answers to questions related to Steglatro (Ertugliflozin) , see some other helpful Q&A related to this product.
Question: What should you do if you experience symptoms of ketoacidosis while taking Steglatro?
Answer: Stop taking Steglatro and call your doctor if you experience symptoms of ketoacidosis, including abdominal pain, nausea, vomiting, fatigue, and breathing problems. Prompt action can prevent serious health complications.
Question: What is Steglatro used for?
Answer: Steglatro is used with diet and exercise to help control blood sugar levels in adults with type 2 diabetes. This usage helps manage diabetes effectively, reducing the risk of complications.
Question: What are the contraindications for using Steglatro?
Answer: Do not take Steglatro if you are allergic to ertugliflozin or any other ingredients in Steglatro, or if you are on dialysis. Avoiding these contraindications helps prevent severe allergic reactions and complications.
Question: What is the KEGG identifier for Steglatro?
Answer: The KEGG identifier for Steglatro is D10313. This database entry provides information on the drug's biochemical pathways and interactions.
Question: What is the PubChem CID for Steglatro?
Answer: The PubChem CID for Steglatro is 44814423. This unique identifier is useful for looking up detailed chemical and pharmacological information.
Question: What are the available dosages of Steglatro?
Answer: Steglatro is available in 5 mg and 15 mg tablets. Different dosages allow for personalized treatment plans based on individual patient needs.
Question: What is the bioavailability of Steglatro?
Answer: The bioavailability of Steglatro is approximately 100%. High bioavailability means that almost the entire dose of the drug is absorbed into the bloodstream, ensuring its effectiveness.
